Dalton Transactions
Paper
Synthesis of PCB-C3-CB
64.33, 51.84, 35.11, 34.85, 34.07, 33.65, 33.10, 29.25, 28.60,
28.23, 25.37, 22.38, 22.35, 13.91. 11B NMR (CDCl3): δ ppm:
−3.8 (br s, 3B), −10.4 (br s, 7B). MALDI-TOF MS: m/z calcd for
C89H46B10O2, 1256.4; found, 1256.7. Anal. calcd for
C89H46B10O2: C 85.15, H 3.69; found: C 85.05, H 3.60.
A procedure analogous to that for PCB-Ph-CB was employed
with 3b. The product was obtained as a brown solid (56%). H
1
NMR (CDCl3): δ ppm: 7.92–7.87 (m, 2H), 7.56–7.51 (m, 2H),
7.49–7.44 (m, 3H), 7.15 (d, J = 8.4 Hz, 2H), 3.82 (t, J = 6.2 Hz,
2H), 2.86–2.81 (m, 2H), 2.60 (t, J = 7.7 Hz, 2H), 2.35 (t, J = 7.5
Hz, 2H), 2.13–2.03 (m, 2H), 1.84–1.79 (m, 2H), 1.73–1.65 (m,
2H), 1.63–1.54 (m, 2H), 1.39–1.29 (m, 2H), 0.91 (t, J = 7.3 Hz,
3H). 13C NMR (CDCl3): δ ppm: 172.62, 148.69, 147.72, 145.81,
145.20, 145.16, 145.05, 145.02, 144.80, 144.66, 144.52, 143.76,
143.01, 142.95, 142.16, 142.13, 141.00, 137.57, 132.05, 131.01,
128.91, 128.47, 127.85, 84.05 (CB-C), 81.36 (CB-C), 79.78,
62.89, 51.70, 35.15, 33.77, 33.57, 33.15, 31.45, 28.49, 22.40,
22.23, 13.96. 11B NMR (CDCl3): δ ppm: −3.7 (br s, 3B), −10.2
(br s, 7B). MALDI-TOF MS: m/z calcd for C86H40B10O2, 1214.4;
found, 1214.6. Anal. calcd for C86H40B10O2: C 85.13, H 3.32;
found: C 85.10, H 3.15.
Synthesis of 5a
A procedure analogous to that for 3a was employed with Br-
1
(CH2)11-OTMS, affording 5a as a colorless oil (76%). H NMR
(CDCl3): δ ppm: 7.51–7.46 (m, 2H), 7.15 (d, J = 8.5 Hz, 2H),
3.54 (t, J = 6.7 Hz, 2H), 2.60 (t, J = 7.7 Hz, 2H), 1.75–1.69 (m,
2H), 1.62–1.53 (m, 2H), 1.53–1.44 (m, 2H), 1.38–1.29 (m, 4H),
1.29–0.99 (m, 14H), 0.91 (t, J = 7.2 Hz, 3H), −0.09 (s, 9H). 13C
NMR (CDCl3): δ ppm: 145.74, 130.99, 128.78, 128.12, 83.79
(CB-C), 82.63 (CB-C), 62.71, 35.11, 34.91, 33.14, 32.73, 29.51,
29.41, 29.35, 29.25, 28.92, 28.90, 25.80, 22.33, 13.89, −0.46. 11
B
NMR (CDCl3): δ ppm: −3.8 (br s, 3B), −10.4 (br s, 7B). HR
EI-MS: m/z calcd for C26H54B10OSi, 520.4874; found, 520.4877.
Synthesis of 4a
Synthesis of 5b
A procedure analogous to that for 3a was employed with Br-
(CH2)6-OTMS, affording 4a as a colorless oil (74%). 1H NMR
(CDCl3): δ ppm: 7.49 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 8.4 Hz,
2H), 3.46 (t, J = 6.6 Hz, 2H), 2.60 (t, J = 7.7 Hz, 2H), 1.76–1.70
(m, 2H), 1.63–1.54 (m, 2H), 1.41–1.30 (m, 6H), 1.19–1.01 (m,
4H), 0.91 (t, J = 7.3 Hz, 3H), −0.06 (s, 9H). 13C NMR (CDCl3): δ
ppm: 145.77, 130.98, 128.80, 128.09, 83.80 (CB-C), 82.53 (CB-
C), 62.32, 35.10, 34.90, 33.11, 32.32, 29.37, 28.76, 25.22, 22.33,
−0.52. 11B NMR (CDCl3): δ ppm: −3.8 (br s, 3B), −10.4 (br s,
7B). HR EI-MS: m/z calcd for C21H44B10OSi, 450.4092; found,
450.4090.
A procedure analogous to that for 3b was employed with 5a,
affording 5b as a colorless oil (75%). H NMR (CDCl3): δ ppm:
1
7.48 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 3.61 (s, 2H),
2.60 (t, J = 7.5 Hz, 2H), 1.75–1.69 (m, 2H), 1.62–1.48 (m, 4H),
1.38–0.97 (m, 19H), 0.91 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3): δ
ppm: 145.73, 130.96, 128.76, 128.07, 83.78 (CB-C), 82.61 (CB-
C), 62.99, 35.08, 34.87, 33.10, 32.74, 29.47, 29.36, 29.35, 29.32,
29.21, 28.87, 25.68, 22.30, 13.86. 11B NMR (CDCl3): δ ppm:
−3.8 (br s, 3B), −10.4 (br s, 7B). HR EI-MS: m/z calcd for
C23H46B10O, 448.4479; found, 448.4482.
Synthesis of PCB-C11-CB
Synthesis of 4b
A procedure analogous to that for PCB-Ph-CB was employed
with 5b, affording the product as a dark brown solid (51%). 1H
NMR (CDCl3): δ ppm: 7.93–7.88 (m, 2H), 7.55–7.42 (m, 5H),
7.15 (d, J = 8.3 Hz, 2H), 4.03 (t, J = 6.7 Hz, 2H), 2.92–2.86 (m,
2H), 2.60 (t, J = 7.7 Hz, 2H), 2.49 (t, J = 7.4 Hz, 2H), 2.21–2.11
(m, 2H), 1.75–1.69 (m, 2H), 1.63–1.53 (m, 4H), 1.39–0.98 (m,
18H), 0.91 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3): δ ppm: 173.09,
148.80, 147.80, 145.84, 145.71, 145.17, 145.12, 145.06, 145.02,
144.77, 144.67, 144.63, 144.48, 144.39, 143.98, 143.74, 143.73,
143.09, 143.01, 142.97, 142.92, 142.89, 142.21, 142.16, 142.11,
142.08, 140.95, 140.72, 138.02, 137.54, 136.73, 132.08, 130.98,
128.78, 128.41, 128.22, 128.09, 83.83 (CB-C), 82.59 (CB-C),
79.88, 64.73, 51.89, 35.11, 34.91, 34.13, 33.66, 33.12, 29.45,
A procedure analogous to that for 3b was employed with 4a,
affording 4b as a colorless oil (70%). H NMR (CDCl3): δ ppm:
1
7.48 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 3.53 (t, J = 6.7
Hz, 2H), 2.60 (t, J = 7.7 Hz, 2H), 1.77–1.70 (m, 2H), 1.63–1.53
(m, 2H), 1.45–1.28 (m, 6H), 1.20–1.03 (m, 5H), 0.91 (t, J = 7.4
Hz, 3H). 13C NMR (CDCl3): δ ppm: 145.79, 130.97, 128.79,
128.05, 83.80 (CB-C), 82.47 (CB-C), 62.65, 35.08, 34.81, 33.09,
32.30, 29.29, 28.68, 25.09, 22.31, 13.86. 11B NMR (CDCl3): δ
ppm: −3.8 (br s, 3B), −10.4 (br s, 7B). HR EI-MS: m/z calcd for
C18H36B10O, 378.3697; found, 378.3694.
Synthesis of PCB-C6-CB
A procedure analogous to that for PCB-Ph-CB was employed 29.43, 29.38, 29.27, 29.25, 28.95, 28.62, 25.92, 22.41, 22.34,
with 4b, affording the product as a brown solid (55%). 1H 13.94. 11B NMR (CDCl3): δ ppm: −3.8 (br s, 3B), −10.3 (br s,
NMR (CDCl3): δ ppm: 7.92–7.88 (m, 2H), 7.55–7.42 (m, 5H), 7B). MALDI-TOF MS: m/z calcd for C94H56B10O2, 1326.5; found,
7.15 (d, J = 8.4 Hz, 2H), 3.95 (t, J = 6.8 Hz, 2H), 2.91–2.85 (m, 1326.0. Anal. calcd for C94H56B10O2: C 85.17, H 4.26; found: C
2H), 2.60 (t, J = 7.7 Hz, 2H), 2.47 (t, J = 7.4 Hz, 2H), 2.19–2.10 85.30, H 4.22.
(m, 2H), 1.75–1.69 (m, 2H), 1.62–1.53 (m, 2H), 1.50–1.42 (m,
2H), 1.40–1.28 (m, 2H), 1.20–1.02 (m, 4H), 0.91 (t, J = 7.2 Hz,
Cyclic voltammetry
3H). 13C NMR (CDCl3): δ ppm: 173.03, 148.78, 147.80, 145.85, Cyclic voltammetry measurement was carried out with a three-
145.20, 145.05, 144.41, 144.01, 143.77, 143.00, 142.95, 142.91, electrode cell configuration consisting of platinum working
142.19, 142.14, 142.10, 140.98, 138.01, 137.57, 132.09, 130.99, and counter electrodes and an Ag/AgNO3 (0.01 M in CH3CN)
128.83, 128.42, 128.25, 83.82 (CB-C), 82.34 (CB-C), 79.87, reference electrode at room temperature. Measurement was
This journal is © The Royal Society of Chemistry 2013
Dalton Trans.